The RhoGEF GEF-H1 Is Required for Oncogenic RAS Signaling via KSR-1-Reference-Cited by-同舟云学术

The RhoGEF GEF-H1 Is Required for Oncogenic RAS Signaling via KSR-1

Published:2014-02 Issue:2 Volume:25 Page:181-195
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Cullis Jane,Meiri David,Sandi Maria Jose,Radulovich Nikolina,Kent Oliver A.,Medrano Mauricio,Mokady Daphna,Normand Josee,Larose Jose,Marcotte Richard,Marshall Christopher B.,Ikura Mitsuhiko,Ketela Troy,Moffat Jason,Neel Benjamin G.,Gingras Anne-Claude,Tsao Ming-Sound,Rottapel Robert

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference63 articles.

1. Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia;Al-Aynati;Clin. Cancer Res.,2004

2. MAP kinases in lung endothelial permeability induced by microtubule disassembly;Birukova;Am. J. Physiol. Lung Cell. Mol. Physiol.,2005

3. Activation of gef-h1, a guanine nucleotide exchange factor for RhoA, by DNA transfection;Brecht;Int. J. Cancer,2005

4. Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos;Buday;Oncogene,1995

5. Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression;Cacace;Mol. Cell. Biol.,1999

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plinabulin, a microtubule destabilising agent, in non-small-cell lung cancer: lessons from the DUBLIN-3 trial;The Lancet Respiratory Medicine;2024-09

2. Regulation of the RhoA exchange factor GEF-H1 by profibrotic stimuli through a positive feedback loop involving RhoA, MRTF, and Sp1;American Journal of Physiology-Cell Physiology;2024-08-01

3. Amplifying colorectal cancer progression: impact of a PDIA4/SP1 positive feedback loop by circPDIA4 sponging miR-9-5p;Cancer Biology & Medicine;2024-06-21

4. Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer;Cellular Signalling;2023-09

5. Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality;Journal of Translational Medicine;2023-05-11